PC
PRVA icon

Pier Capital’s Privia Health PRVA Stock Holding History

Pier Capital’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09M Buy
159,123
+482
+0.3% +$11.2K 0.54% 87
2026
Q1 		$3.26M Sell
158,641
-196,618
-55% -$4.43M 0.54% 82
2025
Q4 		$8.42M Sell
355,259
-1,907
-0.5% -$46.4K 1.34% 23
2025
Q3 		$8.89M Buy
357,166
+45,168
+14% +$972K 1.39% 20
2025
Q2 		$7.18M Sell
311,998
-99,810
-24% -$2.31M 1.09% 46
2025
Q1 		$9.25M Buy
411,808
+11,319
+3% +$263K 1.55% 13
2024
Q4 		$7.83M Buy
400,489
+10,594
+3% +$210K 1.12% 47
2024
Q3 		$7.1M Buy
389,895
+84,786
+28% +$1.62M 1% 54
2024
Q2 		$5.3M Sell
305,109
-32,592
-10% -$577K 0.79% 68
2024
Q1 		$6.62M Buy
337,701
+10,153
+3% +$214K 0.91% 54
2023
Q4 		$7.54M Sell
327,548
-3,449
-1% -$77.2K 1.08% 50
2023
Q3 		$7.61M Sell
330,997
-4,479
-1% -$114K 1.23% 28
2023
Q2 		$8.76M Buy
335,476
+7,084
+2% +$187K 1.26% 30
2023
Q1 		$9.07M Buy
328,392
+134,190
+69% +$3.54M 1.38% 17
2022
Q4 		$4.41M Buy
+194,202
New +$5.41M 0.72% 70

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Pier Capital's PRVA Position: Q2 2026 in Review

Pier Capital increased its Privia Health (PRVA) stake by 0.3% in Q2 2026, buying an estimated $11.2K and bringing the position to 159,123 shares worth $4.09M. The position accounts for 0.54% of the portfolio, ranked #87.

Pier Capital first reported a position in PRVA in Q4 2022 and has held it in 15 quarters since. The position peaked at $9.25M in Q1 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Pier Capital held 159,123 shares of Privia Health worth $4.09M as of Q2 2026.
  • Pier Capital bought 482 Privia Health shares in Q2 2026, an estimated $11.2K.
  • Privia Health made up 0.54% of Pier Capital's portfolio in Q2 2026, its #87 holding.
  • Pier Capital first reported a position in Privia Health in Q4 2022 and has held it in 15 quarters since.
  • Pier Capital's Privia Health position peaked at $9.25M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.